Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.22 Analyst target: $18.00 Upside: 710.81%
Artelo Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. The company is headquartered in La Jolla, California.
See the full interactive analysis & chart →Informational only — not investment advice.